I. Urbino

Myeloid Neoplasms with Eosinophilia: Rare Entities with Emerging Diagnostic and Therapeutic Challenges.

G. Benevolo, I. Urbino, 2020, Acta haematologica.

Gilteritinib in Isolated Breast Relapse of FLT3 Positive Acute Myeloid Leukemia: A Case Report and Review of Literature

R. Freilone, M. Cerrano, E. Audisio, 2022, Acta Haematologica.

Polycythemia Vera (PV): Update on Emerging Treatment Options

G. Benevolo, V. Giai, F. Vassallo, 2021, Therapeutics and clinical risk management.

Evolving Therapeutic Approaches for Older Patients with Acute Myeloid Leukemia in 2021

A. Busca, D. Ferrero, R. Freilone, 2021, Cancers.

Levofloxacin Prophylaxis Versus no Prophylaxis in Acute Myeloid Leukemia During Post-Induction Aplasia: a Single Center Study

F. D. De Rosa, G. Ciccone, R. Rosato, 2023, Mediterranean journal of hematology and infectious diseases.

Frequency and risk factors for thrombosis in acute myeloid leukemia and high-risk myelodysplastic syndromes treated with intensive chemotherapy: a two centers observational study

A. Busca, D. Ferrero, R. Freilone, 2022, Annals of Hematology.

Validation of National Early Warning Score and Quick Sequential (sepsis‐related) Organ Failure Assessment in acute myeloid leukaemia patients treated with intensive chemotherapy

G. Priolo, A. Busca, R. Freilone, 2023, European journal of haematology.

Modern Risk Stratification of Acute Myeloid Leukemia in 2023: Integrating Established and Emerging Prognostic Factors

D. Ferrero, R. Freilone, M. Cerrano, 2023, Cancers.

Multicenter Observational Retrospective Study on Febrile Events in Patients with Acute Myeloid Leukemia Treated with Cpx-351 in “Real-Life”: The SEIFEM Experience

P. Chiusolo, L. Pagano, M. Rondoni, 2023, Cancers.